Streptococcus pneumoniae: serotype distribution, antimicrobial susceptibility, risk factors and mortality in Galicia over a two year-period

Enfermedades infecciosas y microbiología clínica
Susana Méndez-LageGrupo de trabajo del neumococo de los hospitales de Galicia

Abstract

To examine the epidemiology of pneumococcal infection in Galicia (Spain) after the incorporation of the pneumococcal conjugate vaccine, and to determine serotype distribution, antibiotic susceptibility, risk factors and associated mortality in cases of invasive pneumococcal disease (IPD) during 2011 and 2012. All strains causing IPD in Galicia were studied. Serotyping was performed by agglutination and Quellung reaction. Antibiotic sensitivity to penicillin, cefotaxime, erythromycin, vancomycin, and levofloxacin was determined. The risk factors considered were chronic respiratory disease, heart disease, liver disease, kidney disease, diabetes mellitus, and HIV and non-HIV immunodeficiency. A total of 555 strains were collected, with 43 different serotypes being found. The most frequently isolated ones were: serotype3 (17.5%), serotype7F (12.6%), serotype19A (9.4%), serotype14 (4.1%), serotype6C (4.1%), serotype11A (4%) and serotype22F (3.8%). 57.1% of isolates were serotypes included in VNC-13V. Two non-penicillin-sensitive strains and two others were not sensitive to cefotaxime, and 24.7% of the strains were not susceptible to erythromycin (26.9% in 2011 and 22.5% in 2012). The case fatality rate was 16.5%, reaching 23.3% in p...Continue Reading

References

May 2, 2003·The New England Journal of Medicine·Cynthia G WhitneyUNKNOWN Active Bacterial Core Surveillance of the Emerging Infections Program Network
Jun 9, 2004·Journal of Clinical Microbiology·H-C SlotvedF Espersen
Feb 1, 2005·The Lancet Infectious Diseases·William P HausdorffKeith P Klugman
Nov 28, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Carmen ArdanuyJosefina Liñares
Dec 29, 2009·The Journal of Infection·Caroline L TrotterElizabeth Miller
Jan 6, 2010·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Zitta B HarboeHelle B Konradsen
Feb 6, 2010·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·J LiñaresA Fenoll
Aug 19, 2010·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Daniel M WeinbergerMarc Lipsitch
Oct 5, 2010·The European Respiratory Journal·M W PletzK P Klugman
Jun 2, 2011·The Journal of Antimicrobial Chemotherapy·Dora RoloJosefina Liñares
Jun 21, 2011·Vaccine·M Angeles Gutiérrez RodríguezJuan Carlos Sanz Moreno
Dec 2, 2011·Enfermedades infecciosas y microbiología clínica·María Isabel MorosiniCarmen Torres
Mar 8, 2012·The Journal of Infection·Albert Jan van HoekElizabeth Miller
Mar 26, 2013·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·C RockC Bergin
Sep 26, 2013·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Manel LujánJordi Rello
Oct 15, 2013·Medicina clínica·Maria Teresa Pérez-RodríguezMaximiliano Álvarez-fernández

❮ Previous
Next ❯

Citations

Sep 13, 2016·Human Vaccines & Immunotherapeutics
May 5, 2021·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·Maitane Ibar-BariainAlicia Rodríguez-Gascón

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bacterial Pneumonia (ASM)

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Antibodies: Agglutination

Antibody-mediated agglutination is the clumping of cells in the presence of antibody, which binds multiple cells together. This enhances the clearance of pathogens. Find the latest research on antibody-mediated agglutination here.

Bacterial Pneumonia

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Bacterial Meningitis

Bacterial meningitis continues to be an important cause of mortality and morbidity throughout the world. Here is the latest research.

Bacterial Meningitis (ASM)

Bacterial meningitis continues to be an important cause of mortality and morbidity throughout the world. Here is the latest research.

Related Papers

Revista Panamericana De Salud Pública = Pan American Journal of Public Health
Theresa J OchoaAndrés Sáenz
The Brazilian Journal of Infectious Diseases : an Official Publication of the Brazilian Society of Infectious Diseases
de Cunto Brandileone MCR Austrian
The Journal of Antimicrobial Chemotherapy
Astrid BuxbaumAustrian Bacterial Surveillance Network
© 2022 Meta ULC. All rights reserved